Adverum Biotechnologies Inc (ADVM)
3.73
+0.17 +4.78%
NASDAQ
Nov 15, 20:00
Delayed 2m
USD
View All Key Stats
ADVM Key Stats
| Income Statement | |
| Revenue (TTM) | 2.003M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.26 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -71.76M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -2.52K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 234.50M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 106.30 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.088 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -17.17M |
| Return on Equity (TTM) | Upgrade |
View All ADVM News
ADVM News
-
WireHeadlineTime (ET)
-
Globe Newswire11/13 16:30
-
Yahoo11/08 20:30
-
Yahoo11/08 19:30
-
SA Breaking News11/08 16:51
-
Globe Newswire11/08 16:10
-
Globe Newswire11/08 07:50
-
Yahoo11/07 10:30
-
MT Newswires11/05 08:09
-
MT Newswires11/02 16:38
-
Yahoo11/02 15:12
View All Events
ADVM Events
| Date | Type | Description |
|---|---|---|
| 03/06/2019 | Earnings | Adverum Biotechnologies Inc Fourth Quarter Earnings Results in 2018 |
| 11/08/2018 | Earnings | Adverum Biotechnologies Inc Third Quarter Earnings Results in 2018 |
| 08/08/2018 | Earnings | Adverum Biotechnologies Inc Second Quarter Earnings Results in 2018 |
| 05/09/2018 | Earnings | Adverum Biotechnologies Inc First Quarter Earnings Results in 2018 |
| 03/06/2018 | Earnings | Adverum Biotechnologies Inc Fourth Quarter Earnings Results in 2017 |
ADVM Fundamentals
Income Statement View Statement
ADVM Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ADVM One Page Reports
- One Page Report Download
ADVM Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 3.73 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.adverum.com
- Investor Relations URL: http://investors.avalanchebiotech.com/phoenix.zhtml?c=253634&p=irol-irhome
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Mar. 06, 2019
- Last Earnings Release: Nov. 08, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Adverum Biotechnologies Inc is a gene therapy company committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye.
ADVM Excel Add-In Codes
- Name: =YCI("ADVM","name")
- Description: =YCI("ADVM","description")
- Sector: =YCI("ADVM","sector")
- Industry: =YCI("ADVM","industry")
- Est. Current Fiscal Year End: =YCI("ADVM","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ADVM Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ADVM Tweets Stocktwits
Advertisement
